Home|DSIJArticleDetail

This Small-Cap Pharma to Unlock Rs 279 Crore in Cash from Mumbai Property Sale
This Small-Cap Pharma to Unlock Rs 279 Crore in Cash from Mumbai Property Sale

This Small-Cap Pharma to Unlock Rs 279 Crore in Cash from Mumbai Property Sale

Unichem Laboratories' decision to sell its Mumbai property boosts investor confidence as stock hits day's high of Rs 635.10, up 4.66 per cent. The buyer in this transaction is Macrotech Developers Limited

DSIJ Intelligence Article rating: 5.0

Unichem Laboratories' decision to sell its Mumbai property boosts investor confidence as stock hits day's high of Rs 635.10, up 4.66 per cent. The buyer in this transaction is Macrotech Developers Limited

Stocks to watch: These small-cap stocks will be in focus on Monday!
Stocks to watch: These small-cap stocks will be in focus on Monday!

Stocks to watch: These small-cap stocks will be in focus on Monday!

Among the BSE Smallcap were Shiva Cement, Onward Technolgies, Monte Carlo Fashions and Jubilant Pharmova.

DSIJ Intelligence Article rating: 3.9

On Friday, the Sensex rose by 355 points to close at 57,989.90, while the Nifty 50 gained by marginal 114 points to close at 17,100.05

Stocks to watch: These smallcap stocks will be in focus on March 2
Stocks to watch: These smallcap stocks will be in focus on March 2

Stocks to watch: These smallcap stocks will be in focus on March 2

Vadilal Industries, Vaishali Pharma, Rajnandini Metal, Orient Bell, Shankara Building Products and Fine Organic Industries made a fresh 52-week high today.  

DSIJ Intelligence Article rating: 4.1

BSE Smallcap index replicated the broader market trend, gaining 0.80 per cent i.e. 211.95 points and closing at 26,662.33.  

T20 breakout stocks: Best swing trading stocks to keep an eye on!
T20 breakout stocks: Best swing trading stocks to keep an eye on!

T20 breakout stocks: Best swing trading stocks to keep an eye on!

DSIJ Intelligence-3 Article rating: 3.9

We believe that going forward, stock-specific action would continue to be the name of the game on D-Street and hence, we have selected the best stock for traders as well as investors based on the T20 Breakout system.   

DSIJ MINDSHARE

Mkt Commentary23-Apr, 2025

Multibaggers23-Apr, 2025

Mindshare23-Apr, 2025

Mindshare23-Apr, 2025

Bonus and Spilt Shares23-Apr, 2025

Knowledge

MF22-Apr, 2025

MF17-Apr, 2025

General22-Mar, 2025

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

SEBI Registered Research Analyst Details:
Registered Name: DSIJ PRIVATE LIMITED
Type of registration: Non-Individual
Registration No.: INH000006396
Validity: Oct 05, 2018 - Perpetual
BSE Enlistment No. 5307

SEBI Registered Investment Adviser Details:
Registered Name: DSIJ PRIVATE LIMITED
Type of registration: Non-Individual
Registration No.: INA000001142
Validity: Aug 19, 2019 - Perpetual
BSE Enlistment No. 1346

Registered and Correspondence Office Address :
DSIJ PVT LTD. Office No - 409,
Solitaire Business Hub, Kalyani Nagar, Pune - 411006
Tel: +91 022-43476012/13/14/15 | Email: service@dsij.in
CIN No.: U22120MH2003PTC139276
GST No.: 27AACCR4303G1ZP

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR

Disclaimer: "Registration granted by SEBI, membership of BASL and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors"

Investment in securities market is subject to market risks. Read all the related documents carefully before investing.

Any act of copying, reproducing, or distributing the content whether wholly or in part, for any purpose without the permission of DSIJ is strictly prohibited and shall be deemed to be copyright infringement.

Disclosures | Terms & Conditions | Privacy Statement | WhiteList